Most lists of low-testosterone symptoms are useless because they are indiscriminate. Fatigue, weight gain, poor sleep, low mood and reduced concentration appear on every one of them. Those symptoms are produced by a dozen conditions that are more common than hypogonadism, and they show almost no relationship to measured testosterone in population data.
A small number of symptoms do track the hormone. The European Male Ageing Study, which measured testosterone and symptoms in roughly 3,400 men aged 40 to 79, found that only three symptoms clustered consistently with low levels: loss of morning erections, reduced sexual desire, and erectile difficulty. Everything else on the standard list failed to hold a relationship once the numbers were checked. That single finding is the most useful filter available before you spend money on testing or treatment.
The Verdict
Which symptoms actually correlate with the numbers
The table below separates symptoms by how specifically they point at testosterone. Specificity matters more than frequency here. Fatigue is the most common complaint men bring to a hormone consult and one of the least informative. Loss of morning erections is less commonly volunteered and considerably more informative.
| Symptom | How specific to low testosterone | What else commonly causes it |
|---|---|---|
| Loss of morning erections | High — one of three symptoms with a consistent link to low testosterone | Vascular disease, SSRIs, sleep fragmentation, alcohol |
| Reduced sexual desire | High — tracks measured testosterone more closely than any other complaint | Depression, SSRIs, relationship factors, opioids, hyperprolactinemia |
| Erectile difficulty | Moderate to high — but usually vascular before it is hormonal | Endothelial disease, diabetes, blood-pressure medication, anxiety |
| Fatigue and low energy | Low — extremely common at any testosterone level | Sleep apnea, anemia, thyroid disease, iron deficiency, depression |
| Depressed mood and irritability | Low — overlaps almost completely with primary depression | Depression, chronic stress, thyroid disease, poor sleep |
| Loss of muscle and rising waist size | Low to moderate — slow and confounded by activity and calories | Reduced training volume, protein intake, aging, insulin resistance |
| Reduced concentration ("brain fog") | Low — no reliable relationship with measured levels | Sleep debt, thyroid disease, B12 deficiency, stress, alcohol |
| Hot flushes and sweats | High when present, but uncommon and usually severe deficiency | Rare in men otherwise; consider medication effects and thyroid |
| Reduced body and facial hair, small or shrinking testes | High — a physical sign, not a subjective one | Almost always endocrine; warrants prompt evaluation |
| Breast tenderness or gynecomastia | Moderate — reflects the testosterone-to-estradiol ratio | Medications, liver disease, cannabis, hCG-containing products |
Two patterns in that table deserve attention. First, the physical signs — shrinking testes, reduced body hair, gynecomastia — carry far more diagnostic weight than any subjective symptom, and they are the ones men rarely mention. Second, symptoms rarely arrive alone. A man with three or more of the high-specificity items has a meaningfully different pre-test probability than a man reporting fatigue in isolation.
The numbers, with age and assay context
Reference ranges at most commercial labs are built from mixed-age adult male populations and are not age-adjusted. That has a practical consequence: a 62-year-old at the bottom of the "normal" range is being compared with 25-year-olds. Total testosterone declines roughly 1% per year from around age 30 to 40 onward, while SHBG rises at a similar rate, so free testosterone declines faster than total.
| Marker | Typical adult male reference | Threshold that changes the decision | Age and interpretation notes |
|---|---|---|---|
| Total testosterone | 300–1,000 ng/dL (10.4–34.7 nmol/L) | Below 300 ng/dL (AUA) or below 264 ng/dL (Endocrine Society, CDC-harmonized assay) on two separate morning draws | Falls roughly 1% per year after age 30–40; reference ranges are not age-adjusted at most labs |
| Calculated free testosterone | 5–21 ng/dL (50–210 pg/mL) | Below about 6.5 ng/dL (65 pg/mL) is commonly treated as low | Falls faster than total with age because SHBG rises; this is the number that most often explains symptoms |
| SHBG | 10–57 nmol/L | No treatment threshold — it is the interpreter for the other two | Rises roughly 1% per year after 40; higher in lean, older, hyperthyroid, or hepatically stressed men |
| LH | 1.7–8.6 IU/L | High LH with low T = testicular (primary). Low or normal LH with low T = pituitary/hypothalamic (secondary) | Secondary is far more common in men over 40 and is where reversible causes live |
| Estradiol (LC/MS sensitive assay) | 10–40 pg/mL in men | No independent treatment threshold | Rises with body fat via aromatase; the standard immunoassay is unreliable at male concentrations |
| Prolactin | Under about 15 ng/mL | Persistent elevation warrants pituitary imaging, especially with total T under 150 ng/dL | A prolactinoma is uncommon but is the reason low T with low LH is not a prescription on its own |
The free testosterone number deserves the most attention in men over 40. Because SHBG climbs with age, a man can hold a flat total testosterone for fifteen years while his usable fraction falls by a third. Calculated free testosterone — derived from total, SHBG and albumin using the Vermeulen equation — is more reproducible than most direct free-testosterone assays and is what a competent panel reports.
How it is tested, and what invalidates the result
A testosterone result is only as good as the conditions it was drawn under. More men are misdiagnosed by a badly-timed draw than by a bad assay. The list below covers the errors that actually change the answer.
| What invalidates the test | Why | What to do instead |
|---|---|---|
| Afternoon or evening draw | Testosterone peaks in the early morning and can read 20–25% lower by late afternoon in men under 45 | Draw between 7am and 10am |
| A single draw | Day-to-day variation alone can move a man across the 300 ng/dL line | Two draws on separate days before any diagnosis |
| Acute illness, injury, surgery, or hospitalization | Suppresses the hypothalamic-pituitary-gonadal axis transiently | Wait until recovered, then retest |
| Recent heavy training or extreme calorie restriction | Both transiently suppress the axis | Test in a normal training and eating week |
| Biotin supplements | High-dose biotin interferes with many immunoassays and can skew hormone results in either direction | Stop biotin for 48–72 hours before the draw |
| Standard (non-sensitive) estradiol assay | Validated at female concentrations, unreliable at male ones | Order the LC/MS sensitive estradiol by name |
| Already on testosterone, hCG, enclomiphene, or SARMs | The result reflects the drug, not your own production | Baseline testing must precede therapy — it cannot be reconstructed later |
Fingerstick and at-home collection kits are convenient and, when run by an accredited lab, broadly acceptable for total testosterone screening. They are less reliable for SHBG-derived free testosterone and for sensitive estradiol. If a home kit returns a borderline result, confirm it with a venous morning draw before making any decision.
What raises and lowers testosterone
Low testosterone in a man over 40 is usually secondary — the pituitary signal is down, not the testes failing. That distinction matters because secondary hypogonadism is where the reversible causes live, and because LH on the panel is what tells you which one you have.
| Factor | Direction | Mechanism and magnitude |
|---|---|---|
| Obstructive sleep apnea | Lowers it | Fragmented sleep blunts the overnight LH pulses that drive production. Testosterone therapy can worsen untreated apnea. |
| Excess visceral fat | Lowers it | Adipose aromatase converts testosterone to estradiol, and the resulting estradiol suppresses LH. Roughly 10% weight loss has been associated with a meaningful rise in total testosterone. |
| Chronic short sleep | Lowers it | One week of five-hour nights reduced daytime testosterone by 10–15% in healthy young men in a controlled study. |
| Opioids | Lowers it | Chronic opioid use suppresses the axis in a large share of long-term users. Frequently the entire explanation. |
| Long-term glucocorticoids | Lowers it | Suppress LH and directly affect testicular steroidogenesis. |
| Heavy alcohol use | Lowers it | Direct testicular toxicity plus disrupted sleep architecture. |
| Anabolic steroid or SARM use, past or present | Lowers it | Exogenous androgens suppress endogenous production, sometimes for years after stopping. |
| Hemochromatosis and iron overload | Lowers it | Iron deposition in the pituitary. Uncommon, genuinely reversible, and easy to screen with ferritin and transferrin saturation. |
| Untreated hypothyroidism | Mimics it | Produces the same fatigue, low mood, low libido and weight gain, without moving testosterone much. |
| Resistance training and adequate protein | Raises free testosterone modestly | The effect on serum levels is small; the effect on the symptoms attributed to low T is large. |
| Correcting vitamin D deficiency | Raises it modestly, in deficient men only | Repletion in genuinely deficient men has shown small increases. No effect in replete men. |
| Weight loss with GLP-1 medication or diet | Raises it | Reducing aromatization is one of the few reliable non-pharmacologic ways to move the number. |
Sleep apnea is worth singling out. The symptom overlap with low testosterone is close to total — daytime fatigue, low mood, poor concentration, weight gain, reduced libido — and testosterone therapy can worsen untreated apnea rather than help it. Any man who snores, carries weight around the neck and waist, or wakes unrefreshed should be tested before hormones enter the conversation.
Two entries on that table are worth following further. The adipose row is really about visceral fat specifically rather than body weight in general — it is the metabolically active depot where aromatase activity sits, which is why waist measurement predicts the estradiol picture better than BMI does. And the dietary factor men ask about most is not on the table at all, because the evidence does not put it there: whether soy lowers testosterone has been tested directly in men, and the trials do not support the claim.
Reading the panel as a set
Individual values decide very little. Combinations decide almost everything. The men's hormone panel covers what to order and why each marker earns its place; the patterns below are what the completed set looks like once the results are back:
- Low total, high LH and FSH. Primary hypogonadism — the testes are not responding. Consider a karyotype in younger men, and a history of mumps orchitis, trauma, chemotherapy or undescended testis. Reversible causes are unlikely here.
- Low total, low or inappropriately normal LH. Secondary hypogonadism. This is where obesity, opioids, sleep apnea, alcohol, prior steroid use and prolactin excess live. Check prolactin, iron studies and a full medication list before anything else.
- Normal total, high SHBG, low free. The most common pattern in lean, older men and the one standard care misses. Look at thyroid function, liver health, anticonvulsants and alcohol intake, which all raise SHBG.
- Normal or low total, low SHBG, normal free. Typical of insulin resistance and central obesity. The metabolic work here does more than a hormone prescription would.
- Low total with high estradiol. Points at aromatization from excess adipose tissue. Fat loss addresses both sides of the ratio at once.
- Low total with high ferritin and transferrin saturation. Screen for hemochromatosis. It is uncommon and it is treatable.
Treatment options and their real trade-offs
If the diagnosis holds after two morning draws and a reversible-cause workup, several paths exist. They are not interchangeable.
- Treat the cause first. Continuous positive airway pressure for apnea, weight loss, opioid tapering with the prescribing physician, thyroid replacement, or phlebotomy for iron overload. This is the only option that does not suppress your own production, and in secondary hypogonadism it frequently works.
- Testosterone replacement. Effective for sexual symptoms, bone density, lean mass and mood. It suppresses LH and FSH, which reduces sperm production and testicular volume, and it is usually a long-term commitment. Delivery options and their trade-offs are covered in the delivery method comparison.
- Enclomiphene or clomiphene. Selective estrogen receptor modulators that raise LH and therefore endogenous testosterone. They preserve fertility and testicular size. They only work in secondary hypogonadism with a functioning testicular response, and long-term outcome data is thinner than for testosterone itself.
- hCG. Mimics LH directly. Used alone to preserve fertility, or alongside testosterone to maintain testicular volume and intratesticular testosterone. Adds cost and an additional injection schedule.
- No treatment, with monitoring. A legitimate choice for a man with a borderline number, mild symptoms, and reversible factors still in play. Retesting in six months after addressing sleep and weight often changes the picture.
Safety, contraindications and monitoring
Testosterone therapy has specific contraindications and a defined monitoring schedule. Both are worth knowing before a first appointment, because a clinic that skips them is telling you something about its standards.
- Do not start with active breast or prostate cancer, an unevaluated prostate nodule or elevated PSA, hematocrit above roughly 50% at baseline, untreated severe obstructive sleep apnea, uncontrolled heart failure, a recent cardiovascular event, a known thrombophilia, or a desire to conceive in the near term.
- Monitor hematocrit at 3, 6 and 12 months, then annually. Above roughly 54%, most prescribers reduce the dose, extend the interval, or pause. Erythrocytosis is the most common adverse effect of therapy.
- Monitor PSA in men over 40 at baseline, then at 3–12 months and annually. A rise greater than 1.4 ng/mL within a year warrants urology input.
- Recheck testosterone levels at 6–12 weeks after starting or changing a dose, timed consistently relative to the injection or application.
- Cardiovascular safety. The TRAVERSE trial, published in 2023, randomized roughly 5,200 middle-aged and older men with hypogonadism and cardiovascular risk to transdermal testosterone or placebo, and found no increase in major adverse cardiac events. It did find higher rates of pulmonary embolism, atrial fibrillation and acute kidney injury in the testosterone group. The cardiovascular question is better settled than it was; it is not closed.
- Fertility. Exogenous testosterone suppresses spermatogenesis in most men within months. Recovery after stopping is common but can take a year or more and is not guaranteed. Sperm banking, hCG or a SERM-based alternative belongs in the conversation before the first dose.
When to see a physician
Some presentations are not candidates for a direct-to-consumer panel or a telehealth subscription and should go to a physician promptly: total testosterone under 150 ng/dL, visual field changes or persistent new headaches, nipple discharge, testicular pain, asymmetry or shrinkage, gynecomastia that developed quickly, or an abrupt rather than gradual loss of libido. Each raises the possibility of a pituitary lesion, a testicular problem, or a systemic illness that a hormone prescription would mask rather than treat.
Anyone already taking an opioid, a glucocorticoid, an anticonvulsant, or finasteride should have the medication reviewed as part of the workup rather than after it. And anyone who has used anabolic steroids or SARMs should say so at the first appointment — the recovery protocol is different, and the baseline is not interpretable without that history.
Frequently Asked Questions
What are the first signs of low testosterone in men over 40?
The three symptoms with the most consistent relationship to measured testosterone are loss of morning erections, reduced sexual desire, and erectile difficulty. The European Male Ageing Study found that only these three clustered reliably with low levels. Fatigue, low mood and brain fog are far more common complaints but correlate poorly, because dozens of other conditions produce them. If none of the three sexual symptoms is present, low testosterone is a less likely explanation for whatever else you are feeling.
Can you have low testosterone with normal total testosterone?
Yes, and it is the most common missed pattern in men over 40. Roughly 98% of circulating testosterone is bound, most of it tightly to SHBG. SHBG rises with age, with hyperthyroidism, with liver disease and with some medications. A man at 520 ng/dL total with SHBG of 70 nmol/L can have less usable free testosterone than a man at 340 ng/dL with SHBG of 20. Total alone cannot show that. Free testosterone and SHBG have to be on the same panel.
What testosterone level is considered low?
The American Urological Association uses total testosterone below 300 ng/dL on two separate early-morning draws. The Endocrine Society uses 264 ng/dL on a CDC-harmonized assay. Calculated free testosterone below roughly 6.5 ng/dL (65 pg/mL) is commonly treated as low regardless of total. All of these thresholds require symptoms to be present. A low number without symptoms is a reason to look for a cause, not a reason to prescribe.
Does a symptom questionnaire diagnose low testosterone?
No. The ADAM questionnaire, still used at intake in many clinics, has reasonable sensitivity but poor specificity — roughly 60% in validation work. It flags most men with low testosterone and also flags a large share of men with normal levels. A clinic that prescribes from a questionnaire plus one afternoon draw has not made a diagnosis. Two morning draws with the full panel is the minimum.
What should be ruled out before starting TRT?
Obstructive sleep apnea, obesity, thyroid disease, prolactin excess, iron overload, chronic short sleep, heavy alcohol use, past or current anabolic steroid use, and medications — particularly opioids and long-term glucocorticoids. Several are reversible. Reversing them can move levels enough that lifelong therapy stops being the question, which matters because starting therapy suppresses your own production.
Will testosterone therapy fix fatigue and brain fog?
Sometimes, but this is where expectations most often break. Trials show the clearest effects on sexual desire, erectile function, mood, bone density, and body composition. Effects on energy and cognition are smaller and less consistent. If fatigue is the dominant complaint, sleep apnea, iron deficiency, thyroid disease and depression are more likely explanations, and testosterone will not treat any of them.
When should I see a physician urgently rather than order a home test?
Shrinking testes, breast enlargement or tenderness, visual field loss or persistent headaches, milk-like nipple discharge, total testosterone under 150 ng/dL, or infertility on a semen analysis. Each points toward a pituitary or testicular cause that needs evaluation rather than a subscription protocol. Loss of libido that began abruptly rather than gradually also deserves a proper workup.
Related
- Free vs total testosterone — how SHBG changes the answer
- SHBG explained — the binding protein that governs usable testosterone
- TRT delivery methods compared — injections, cream and pellets side by side
- TRT clinics compared — the same rubric applied to each
- Doctor-led options — physician-supervised platforms on one rubric